LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
24h
Current
Min
1.88
Max
1.99
Recommendations | Buy |
---|---|
12 Months Forecast | +431.91% upside |
Next Earnings | 11 Aug 2025 |
---|
Past performance is not a reliable indicator of future results.
10 Mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Read
10 Mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Read
10 Mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Read
10 Mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Read
10 Mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Read
10 Mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
10 Mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 10 USD 431.91%
High 16 USD
Low 4 USD
Based on 2 Wall Street analysts offering 12 month price targets forFortress Biotech Inc - Dist in the last 3 months.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Based on 2 analysts giving stock ratings to Fortress Biotech Inc - Dist in the past 3 months.
$